[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.237.138.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1959

Effect of 2% Levo-Rotary Epinephrine on the Intraocular Pressure of the Glaucomatous Eye

Author Affiliations

Milwaukee; Chicago; Cleveland; Chicago
Marquette University School of Medicine and County General Hospital (Dr. Garner); University of Illinois Eye and Ear Infirmary (Dr. Johnstone), and Western Reserve University School of Medicine (Dr. Ballintine).

AMA Arch Ophthalmol. 1959;62(2):230-238. doi:10.1001/archopht.1959.04220020056008
Abstract

The use of epinephrine in the treatment or management of glaucoma has been known to ophthalmologists since the beginning of the century. It was not until Hamburger1 popularized epinephrine, in 1923, that much was done in the matter of treating all glaucomas by this means. As a result of the indiscriminate use of "Glaucosan,"2 introduced by Hamburger in 1925, and "Levo-Glaucosan"2 in 1926, the drug fell into disrepute, primarily because of a lack of knowledge as to what is now known as the open- and closed-angle types of glaucoma. Hypertensive patients noted vertigo, tachycardia, and collapse, since the drug was employed in pledget, topical, retrobulbar, and ointment form, and it was not long before the popularity of this preparation waned. Recent study of the sympathomimetic amines3,4 again produces evidence of the tension-lowering qualities of levo-epinephrine and explains its mode of action as due to a decrease

×